Amphetamine anorexia and hypothalamic catecholamines in genetically obese mice (obob)

Area of Science:

• Pharmacology
• Neuroscience
• Obesity Research

Background:

• Genetically obese mice (obob) exhibit hyperphagia, hyperglycemia, and elevated hypothalamic norepinephrine (NE).
• Understanding the anorectic effects of amphetamine in obesity models is crucial for developing therapeutic strategies.

Purpose of the Study:

• To investigate the dose-dependent anorectic effects of amphetamine in obob mice.
• To compare amphetamine's efficacy in obese versus lean mice, considering brain drug levels.

Main Methods:

• Obob and lean mice were subjected to a restricted feeding schedule and treated with varying doses of amphetamine.
• Food intake, body weight, and hypothalamic NE levels were measured.
• Brain amphetamine concentrations were analyzed based on body weight and adjusted doses.

Main Results:

• Amphetamine decreased food intake and hypothalamic NE levels in both lean and obob mice in a dose-dependent manner.
• In obob mice, amphetamine normalized food intake and NE levels compared to lean mice at equivalent brain concentrations.
• Obese mice exhibited higher brain amphetamine levels than lean mice when administered on a body weight basis.

Conclusions:

• Amphetamine acts as an effective anorectic agent in genetically obese mice.
• The study highlights the role of hypothalamic NE in amphetamine's appetite-suppressing effects.
• Differential drug distribution or metabolism may influence amphetamine's anorectic potency in obesity.